Citations

Clear

9383 citation(s) found for "Thomas, PS".

Total Intravenous Anesthesia for Open Spine Procedures: Comparative Analysis of Opioid Infusions
Höfer, R , Hofer, Mikaela M., Sims, Charles R. , Stewart, Thomas M. , Fogelson, Jeremy L. , Hanson, Andrew C. , Gilbertson, Brianna R., Hofer, Ryan E., Hofer, Mikaela M., Warner, Matthew A.

Mayo Clinic

Anesthesia & Analgesia | December 17, 2024 | Volume: 140 | Issue: 6 | Pages: 1498-1500

10.1213/ane.0000000000007343 | PMID 39689003 Get It

Hiatal Hernia and Zenker's Diverticulotomy Outcomes
Wallerius, Katherine P. , Peraza, Lazaro R. , Ali, Hawa M. , O’Byrne, Thomas J., Bayan, Semirra L. , Song, Louis Wong Kee, Ekbom, Dale C. , Awadallah, Andrew S. , Bayan, Semirra

Mayo Clinic

Otolaryngology–Head and Neck Surgery | December 15, 2024 | Volume: 172 | Issue: 3 | Pages: 947-952

10.1002/ohn.1086 | PMID 39675042 Get It

AbstractObjectiveTo compare reflux symptoms, Zenker's diverticulum recurrence, and clinical outcomes in patients with and without a history of hiatal hernia who underwent Zenker's diverticulotomy (ZD).Study DesignSingle institution retrospective review.SettingTertiary care academic hospital.MethodsA retrospective review of patients with and without a history of hiatal hernia who underwent ZD via an open stapler, rigid endoscopic CO2 laser, stapler, or harmonic scalpel technique from January 2006 to December 2020 was performed. Data were abstracted for patient demographics, reflux symptoms, and rates of adverse events and symptomatic recurrence.ResultsA total of 426 patients were included in the study, 97 (22.8%) of which had a history of hiatal hernia. Eleven patients (11.3%) with a history of hiatal hernia had undergone Nissen fundoplication prior to ZD. Patients with a history of hiatal hernia showed less symptomatic improvement postoperatively. Significant differences were noted in the change in the Eating Assessment Tool (EAT‐10) (P < .01) and Reflux Symptom Index (RSI) (P = .03) where patients without a history of hiatal hernia improved more than hiatal hernia patients. Despite these differences in symptom relief, rates of postoperative complications and rates of recurrence did not significantly differ between groups. The median time to recurrence was similar for both groups.ConclusionPatients without a history of hiatal hernia had significantly larger improvements in EAT‐10 and RSI scores compared to patients with a history of hiatal hernia. However, these differences in scores may not represent clinically meaningful differences. There were no significant differences in postoperative adverse events or in recurrence of the Zenker's diverticulum between groups.
Diagnosis and management of dilated cardiomyopathy: a systematic review of clinical practice guidelines and recommendations
Sorella, Anna, Galanti, Kristian , Iezzi, Lorena , Gallina, Sabina , Mohammed, Selma F. , Sekhri, Neha, Akhtar, Mohammed , Prasad, Sanjay, Chahal, Choudhary Anwar Ahmed, Ricci, Fabrizio , Khanji, Mohammed Y , Khanji, Mohammed Yunus , Ricci, Fabrizio , Chahal, Choudhary Anwar Ahmed

Mayo Clinic

European Heart Journal - Quality of Care and Clinical Outcomes | December 15, 2024 | Volume: 11 | Issue: 2 | Pages: 206-222

10.1093/ehjqcco/qcae109 | PMID 39674807 Get It

Abstract Dilated cardiomyopathy (DCM) is extensively discussed in numerous expert consensus documents and international guidelines, with differing recommendations. To support clinicians in daily practice and decision-making, we conducted a systematic review of key guidelines and recommendations concerning the diagnosis and clinical management of DCM. Our research encompassed MEDLINE and EMBASE databases for relevant articles published, as well as the websites of relevant scientific societies. We identified two guidelines and one scientific statement that met stringent criteria, thereby qualifying them for detailed systematic analysis. Our review revealed consensus on several key aspects: the definition of DCM, the use of B-type natriuretic peptides and high-sensitivity troponin in laboratory testing, the essential role of multimodality cardiovascular imaging for initial diagnosis, genetic counselling, and the management of advanced disease. Nonetheless, notable areas of variation included the formation of multidisciplinary management teams, the role of cascade genetic testing, pathways for arrhythmic risk stratification, and the criteria for prophylactic defibrillator implantation. Significant evidence gaps persist, particularly regarding the clinical trajectory of genetic, non-genetic and gene-elusive forms of DCM, the use of cardiovascular magnetic resonance in phenotype-negative family members with genotype-positive probands, and the development of potential aetiology-oriented therapies. Addressing these gaps could enhance clinical outcomes and inform future research directions and guideline development.
Evaluation of a Digital Home Weight Monitoring Program for Infants With Cleft Palate
Sitzman, Thomas J. , Tymous, Kayla, Halvorson, M, Chee-Williams, Jessica L. , Mazon, Jeanette L., Cordero, Kelly Nett , Vaidya, Vinay, Sitzman, Thomas J , Chee-Williams, Jessica L , Mazon, Jeanette L., Singh, Davinder

Mayo Clinic

The Cleft Palate Craniofacial Journal | December 13, 2024 | Volume: 63 | Issue: 4 | Pages: 608-616

10.1177/10556656241307424 | PMID 39668675 Get It

Objective Evaluate the effectiveness of a digital home monitoring program for infants with cleft palate with or without cleft lip (CP ± L), compared to monitoring through in-person clinic visits. Design Retrospective cohort study. Setting One metropolitan pediatric hospital. Patients Eight-eight infants with CP ± L: 41 infants received digital home monitoring and 47 infants were monitored solely through in-person visits. Interventions Beginning in September 2022, all infants with CP ± L were enrolled in a digital home monitoring program, in which caregivers weighed their child weekly at home and submitted those weights, along with subjective evaluations of their child's feeding, using a secure website. Submissions were monitored by the cleft team nurse coordinator. Main Outcome Measures The primary outcome was the incidence of malnutrition at 4 months of age. The secondary outcome was the average number of in-person clinic visits during the first 4 months of life. Results There was not a significant difference ( P = .764) in the incidence of malnutrition between infants monitored in-person compared to infants in the home monitoring program (13% vs 17%). Infants in the home monitoring program had fewer in-person visits with speech–language pathology (5.4 vs 3.9; P < .001). Across groups, malnutrition was associated with Child Protective Services involvement ( P = .001) and presence of a syndrome ( P = .014). Conclusions The digital home monitoring program did not decrease the incidence of malnutrition, but it did reduce the number of speech–language pathology in-person visits. The program appears to distinguish infants who are gaining weight appropriately from those with feeding challenges, but it does not fully address the multifactorial contributors to malnutrition.
Cochlear Implantation With Sporadic Inner Ear Schwannomas: Outcomes in 106 Patients From an International Multi-Institutional Study
Marinelli, John P. , Dornhoffer, James R. , Lohse, Christine M. , Brown, Kevin D. , Lucas, Jacob C. , Babu, Seilesh C. , Lindquist, Nathan R. , Lane, John I. , Harvey, Erin M. , Deep, Nicholas L. , Cerasiello, Samantha Y., Kircher, Matthew L., Espahbodi, Mana , Tooker, Evan L., West, Niels , Cayé‐Thomasen, Per , Carlson, Matthew L., Rahne, Torsten , Cottrell, Justin , Roland, J. Thomas , Thompson, Nicholas J. , Perkins, Elizabeth L. , Tan, Donald , Hunter, Jacob B. , Harvey, Erin, West, Niels Cramer, Carlson, Matthew L. , Plontke, Stefan K.

Mayo Clinic

Otology & Neurotology | December 12, 2024 | Volume: 46 | Issue: 1 | Pages: 10-18

10.1097/mao.0000000000004362 | PMID 39666742 Get It

Objective To evaluate cochlear implant speech perception among patients with sporadic inner ear schwannoma who underwent ipsilateral implantation. Study Design Retrospective multi-institutional cohort study. Setting Eleven tertiary academic medical centers across Germany, Denmark, and the United States. Patients One hundred six patients with sporadic inner ear schwannoma who received an ipsilateral cochlear implant from 2011 to 2022. Interventions Ipsilateral cochlear implantation with observation, stereotactic radiosurgery, or microsurgery for tumor management. Main Outcome Measures Monosyllabic speech perception testing scores and rates of open-set speech perception. Results Among 106 patients studied, 101 (95%) achieved open-set speech perception with a median of 24 months (interquartile range [IQR] 12–42 mo) of audiometric follow-up. Median ipsilateral monosyllabic speech perception testing achieved was 72% (IQR 54–85%), and median ipsilateral AzBio in quiet was 75% (IQR 46–90%). Most (91 of 106 [86%]) underwent microsurgery for tumor control, with cochlear implantation performed simultaneously in 98% (89 of 91) of these patients. The ability to achieve gross total resection significantly differed by tumor complexity, with 97% of low-complexity tumors, 100% of intermediate complexity, and 0% of high-complexity tumors undergoing gross total resection (p < 0.001). However, among patients managed with microsurgery, there was not a statistically significant difference in post-cochlear implantation monosyllabic speech perception scores across complexity groupings, with median scores of 75 and 70% for patients with tumors of low or intermediate complexity and those with tumors of high complexity, respectively (p = 0.5). Eight of 102 patients (8%) assessed experienced deterioration in cochlear implant performance over time. Among the subset of 39 patients with available MRI to review, the region of surveillance interest could be visualized postoperatively on MRI in all cases. Conclusions Open-set speech perception is achieved in most patients with inner ear schwannoma undergoing ipsilateral cochlear implantation. Although cochlear implantation in high-complexity inner ear schwannomas is only possible with incomplete tumor resection, long-term open-set speech perception outcomes are similar to lower-complexity tumors.
Pseudo-HFOs Elimination in iEEG Recordings Using a Robust Residual-Based Dictionary Learning Framework
Besheli, Behrang Fazli , Sha, Zhiyi , Ayyoubi, Amir Hossein , Swamy, Chandra Prakash , Henry, Thomas R. , Miller, Kai J. , Parker, Jonathon J. , Darrow, David , Ince, Nuri F. , Fazli Besheli, Behrang , Worrell, Gregory A.

Mayo Clinic

IEEE Journal of Biomedical and Health Informatics | December 12, 2024 | Volume: 29 | Issue: 2 | Pages: 857-869

10.1109/jbhi.2024.3516613 | PMID 40030514 Get It

Transcytosis as a Mechanism of HIV-1 Entry into Columnar Epithelial Explants of the Female Reproductive Tract
Anderson, Meegan R. , McRaven, Michael D. , Allen, E.J. , Fought, Angela J. , Hope, Thomas J. , Hope, Thomas J , Carias, Ann M. , Allen, Edward

Mayo Clinic

AIDS Research and Human Retroviruses | December 12, 2024 | Volume: 41 | Issue: 3 | Pages: 167-173

10.1089/aid.2024.0045 | PMID 39665594 Get It

Management of Acute Decompensated Valvular Heart Disease
Lüsebrink, Enzo , Lanz, Hugo, Kellnar, Antonia , Karam, Nicole , Makkar, Raj, Abraham, William T. , Leon, Martin B. , Sannino, Anna , Shuvy, Mony , Guerrero, Mayra , Fam, Neil , Butler, Javed, Adamo, Marianna, Rudolph, Volker , Tang, Gilbert , Rommel, Karl-Philipp , Thiele, Holger , Maßberg, Steffen , Prendergast, Bernard, Hausleiter, Jörg , Hausleiter, Jörg , Sannino, Anna , Kapadia, Samir , Makkar, Raj , Latib, Azeem , Guerrero, Mayra , Adamo, Marianna , Stocker, Thomas J. , Lurz, Philipp , Praz, Fabien

Mayo Clinic

European Journal of Heart Failure | December 12, 2024 | Volume: 27 | Issue: 4 | Pages: 630-649

10.1002/ejhf.3549 | PMID 39663714 Get It

Abstract Worldwide, valvular heart disease (VHD) is a common cause of hospitalization for acute heart failure. In acute heart failure caused by VHD, symptoms result from rapid haemodynamic changes and subsequent decline in cardiac function, and if left untreated, leads to acute decompensation and cardiogenic shock. Current evidence remains scarce and recommendations regarding the management of acute heart failure caused by VHD are lacking in most recent international guidelines. Herein, we review the management of acute heart failure caused by VHD with a focus on transcatheter therapies and describe currently available evidence based on a systematic literature search on the following valve pathologies: (i) aortic stenosis, (ii) aortic regurgitation, (iii) mitral regurgitation, and (iv) mitral stenosis. Articles reporting outcomes following urgent or emergent valve intervention in the setting of cardiogenic shock or acute heart failure were considered. After screening a total of 2234 articles, 76 published between 1994 and 2023 were included in subsequent analysis. Based on available evidence, proposed treatment algorithms to guide optimal management of acute heart failure caused by VHD were created. As the number of patients presenting with acute heart failure caused by VHD continues to rise and outcomes following transcatheter valve interventions continue to improve, it is inevitable that minimally invasive options will play an increasingly important role in the acute setting, especially given these patients are at an increased operative risk. This review aims to present an organized approach to the complex management and interventional treatment of patients with acute heart failure caused by VHD.
Influence of Humeral Component Cement and Bone Grafting on Greater Tuberosity Healing and Functional Outcomes After Reverse Shoulder Arthroplasty for Proximal Humerus Fractures
Kaiser, Andrew H.A. , Buchanan, Timothy R. , Bindi, Victoria E. , Holt, K., Reddy, Akshay , Tishad, Abtahi , Hones, Keegan M. , Wright, Jonathan O. , Wright, Thomas W., Holt, Kara E , Reddy, Akshay R , Schoch, Bradley S , King, Joseph J , Hao, Kevin A , Wright, Jonathan O , Hones, Keegan M , Kaiser, Andrew H.A. , Wright, Thomas W. , Schoch, Bradley S. , King, Joseph J. , Hao, Kévin A.

Mayo Clinic

JBJS Reviews | December 11, 2024 | Volume: 12 | Issue: 12 | Pages: No page available

10.2106/jbjs.rvw.24.00148 | PMID 39661712 Get It

Background: Reverse shoulder arthroplasty (RSA) is increasingly used in the treatment of displaced proximal humerus fractures (PHFs) with reliable clinical improvement. However, the preferred techniques for humeral stem fixation are varied and may be influenced by patient and injury characteristics, including bone quality and fracture pattern. This systematic review and meta-analysis sought to determine the effect of humeral component cementing and bone grafting on tuberosity healing rates and functional outcomes after RSA for PHFs. Methods: A systematic review was performed per Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. PubMed/MEDLINE, EMBASE, Web of Science, and Cochrane were queried for clinical studies on RSA performed for PHFs that reported on the use of cemented humeral stems and autograft bone. The primary outcome was the rate of greater tuberosity healing between the various techniques. Secondarily, the authors compared clinical outcomes including postoperative external rotation, forward elevation, abduction, Constant score, and the incidence of complications and revision surgery. Outcomes were compared based on the use of an uncemented press-fit stem, a fully cemented stem without bone graft, or a partially cemented stem with humeral head autograft (i.e., black and tan technique). Results: Forty-eight studies reporting on 1,797 RSAs were included (mean patient age, 75 years; follow-up, 34 months; 81% female). Tuberosity healing was highest in the uncemented cohort, then the black and tan cohort, and lowest in the cemented cohort (80% vs. 70% vs. 61%, p = 0.006). No significant differences in postoperative range of motion, Constant score, complication rates, or revision rates were found. Conclusion: Uncemented fixation with a press-fit stem was associated with superior greater tuberosity healing rates; however, functional outcomes and complications did not differ among techniques. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.
The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma
McCord, Matthew , Sears, Thomas , An, Shejuan, James, C. David , Ruggeri, Bruce , Gueble, Susan , Bindra, Ranjit S. , Horbinski, Craig , Sarkaria, Jann, Bindra, Ranjit , Horbinski, Craig , Sears, Thomas , McCord, Matthew , Wang, Wenxia, Chaliparambil, Rahul Kishore , Sarkaria, Jann N.

Mayo Clinic

Neuro-Oncology | December 11, 2024 | Volume: 27 | Issue: 3 | Pages: 644-651

10.1093/neuonc/noae257 | PMID 39658092 Get It

Abstract Background Acquired resistance to temozolomide (TMZ) chemotherapy due to DNA mismatch repair (MMR) enzyme deficiency is a barrier to improving outcomes for isocitrate dehydrogenase (IDH) wild-type glioblastoma (GBM) patients. KL-50 is a new imidazotetrazine-based therapeutic designed to induce DNA interstrand cross-links, and subsequent double-stranded breaks, in an MMR-independent manner in cells with O-6-methylguanine-DNA methyltransferase (MGMT) deficiency. Previous research showed its efficacy against LN229 glioma cells with MMR and MGMT knockdown. Its activity against patient-derived GBM that model post-TMZ recurrent tumors is unclear. Methods We created MMR-deficient GBM patient-derived xenografts through exposure to TMZ, followed by treatment with additional TMZ or KL-50. We also generated isogenic, MSH6 knockout (KO) patient-derived GBM and tested them for sensitivity to TMZ and KL-50. Results KL-50 extended the median survival of mice intracranially engrafted with either patient-derived TMZ-naïve GBM6 or TMZ-naïve GBM12 by 1.75-fold and 2.15-fold, respectively (P &lt; 0.0001). A low dose (4 Gy) of fractionated RT further extended the survival of KL-50-treated GBM12 mice (median survival = 80 days for RT + KL-50 vs. 71 days KL-50 alone, P = 0.018). KL-50 also extended the median survival of mice engrafted with post-TMZ, MMR-deficient GBM6R-m185 (140 days for KL-50 vs. 37 days for vehicle, P &lt; 0.0001). MSH6 KO increased TMZ IC50 for GBM6 and GBM12 cultures by &gt;5-fold and &gt;12-fold for cell death and live cell count outputs, respectively. In contrast, MSH6-KO actually decreased KL-50 IC50 by 10–80%. Conclusion KL-50-based compounds are a promising new strategy for the treatment of MGMT-deficient, MMR-deficient GBM that recurs after frontline TMZ.